| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 10483 | 2018 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 8241 | 2017 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7380 | 2018 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The lancet 392 (10159), 1923-1994, 2018 | 6585* | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3808 | 2018 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 1062 | 2018 |
| The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ... The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019 | 983* | 2019 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology, 2019 | 609 | 2019 |
| The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 A Etemadi, S Safiri, SG Sepanlou, K Ikuta, C Bisignano, R Shakeri, ... The lancet Gastroenterology & hepatology 5 (1), 42-54, 2020 | 563 | 2020 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 535 | 2018 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 328 | 2018 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 291 | 2019 |
| The economic burden of breast cancer in Iran R Daroudi, AA Sari, A Nahvijou, B Kalaghchi, M Najafi, K Zendehdel Iranian journal of public health 44 (9), 1225, 2015 | 103 | 2015 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … C Fitzmauric, C Fitzmaurice, D Abate, N Abbasi, H Abbastabar, ... JAMA oncology 5 (12), 1749-1768, 2019 | 99 | 2019 |
| Time trends in the occurrence of major GI cancers in Iran B Yazdizadeh, AM Jarrahi, H Mortazavi, MA Mohagheghi, S Tahmasebi, ... Asian Pac J Cancer Prev 6 (2), 130-4, 2005 | 94 | 2005 |
| Burden of breast cancer in Iran: a study of the Tehran population based cancer registry SM Mousavi, MA Mohaghegghi, A Mousavi-Jerrahi, A Nahvijou, ... Asian Pacific Journal of Cancer Prevention 7 (4), 571, 2006 | 82 | 2006 |
| Iran Cancer Statistics in 2012 and projection of cancer incidence by 2035 E Mohebbi, A Nahvijou, M Hadji, H Rashidian, MS Seyyedsalehi, ... Basic & Clinical Cancer Research 9 (3), 3-22, 2017 | 76 | 2017 |
| Clustering of childhood cancer in the inner city of Tehran metropolitan area: a GIS-based analysis A Mosavi-Jarrahi, M Moini, MA Mohagheghi, M Alebouyeh, B Yazdizadeh, ... International journal of hygiene and environmental health 210 (2), 113-119, 2007 | 71 | 2007 |
| Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades A Abdirad, S Ghaderi-Sohi, K Shuyama, C Koriyama, ... Diagnostic Pathology 2, 1-9, 2007 | 62 | 2007 |
| Cost per DALY averted in low, middle-and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds R Daroudi, A Akbari Sari, A Nahvijou, A Faramarzi Cost Effectiveness and Resource Allocation 19, 1-9, 2021 | 58 | 2021 |
Rajabali DaroudiSchool of Public Health, Tehran University of Medical SciencesVerificeret mail på sina.tums.ac.ir
